Back to search

Germany· DE-A57-a1b4f610fd1ef94f

Olmesartan/Amlodipin Heumann

A medicinal product containing olmesartan medoxomil, amlodipine besilate, registered in Germany by Heumann Pharma Gmbh & Co. Generica Kg.

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedOlmesartan/Amlodipin HeumannATC—REGISTER NO.DE-A57-a1b4f610fd1ef9…PACKS LISTED0CHECKEDSeptember 30, 2026

The record

At a glance

EMA Article 57 (European Union)
Active substance
Olmesartan Medoxomil, Amlodipine Besilate
Manufacturer
Heumann Pharma Gmbh & Co. Generica Kg
Country
Germany (DE)
ATC code
—
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ceca4457-e963-4bbe-99ff-da3bf5b28ca5
GET /v1/drugs/ceca4457-e963-4bbe-99ff-da3bf5b28ca5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Olmesartan Medoxomil, Amlodipine Besilate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about olmesartan medoxomil, amlodipine besilate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.